Drug Shortage Report for AXID
Report ID | 239845 |
Drug Identification Number | 00778338 |
Brand name | AXID |
Common or Proper name | Axid |
Company Name | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | NIZATIDINE |
Strength(s) | 150MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 Caps |
ATC code | A02BA |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | |
Actual start date | 2024-10-07 |
Estimated end date | 2024-12-03 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-10-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-10-11 | French | Compare |
v1 | 2024-10-11 | English | Compare |
Showing 1 to 2 of 2